153Sm-labeled Fe3O4@lapatinib nanoparticles as a potential therapeutic agent for breast cancer: synthesis, quality control, and in vivo evaluation-Reference-Cited by-同舟云学术

¹⁵³Sm-labeled Fe₃O₄@lapatinib nanoparticles as a potential therapeutic agent for breast cancer: synthesis, quality control, and in vivo evaluation

Published:2024 Issue:3 Volume:12 Page:678-690
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Pham Thanh Minh¹,Cao Dong Vu¹,Dang Ho Hong Quang¹,Mai Phuoc Minh Thanh¹,Nguyen Thanh Binh¹,Dinh Ngoc Bao Nam¹,Nguyen Thi Khanh Giang¹,Le Thi Mai Huong²,Doan Van Dat³^ORCID,Nguyen Duc Thuan⁴,Le Van Thuan⁵⁶^ORCID

Affiliation:

1. Dalat Nuclear Research Institute, 01 Nguyen Tu Luc, Dalat, 670000, Vietnam

2. Nuclear Training Center, Vietnam Atomic Energy Institute, 140 Nguyen Tuan Street, Thanh Xuan District, Hanoi, 110430, Vietnam

3. The Faculty of Chemical Engineering, Industrial University of Ho Chi Minh City, Ho Chi Minh City, 70000, Vietnam

4. Lam Dong Department of Health, 36 Tran Phu, Lam Dong, 670000, Vietnam

5. Center for Advanced Chemistry, Institute of Research and Development, Duy Tan University, 03 Quang Trung, Da Nang, 550000, Vietnam

6. Faculty of Natural Sciences, Duy Tan University, 03 Quang Trung, Da Nang, 550000, Vietnam

Abstract

Exploring the potential of Fe3O4@lapatinib-153Sm nanoparticles for breast cancer treatment.

Funder

Ministry of Science and Technology

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2024/TB/D3TB01957H

Reference39 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Production of novel recombinant anti-EpCAM antibody as targeted therapy for breast cancer

3. Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer

4. Cancer-macrophage hybrid membrane-camouflaged photochlor for enhanced sonodynamic therapy against triple-negative breast cancer

5. Targeted therapy for breast cancer: An overview of drug classes and outcomes